Letters
Drug company influence
Privatisation should not be NHS policy
BMJ 2019; 365 doi: https://doi.org/10.1136/bmj.l2149 (Published 14 May 2019) Cite this as: BMJ 2019;365:l2149
- Nick Mann, general practitioner
- London E9 7TA, UK
- drnickmann{at}gmail.com
Private sector sponsorship in medicine is known to affect doctors’ behaviour and prescribing activity, published outcomes of research trials, and awarding of contracts.
But it also affects patients’ behaviour, creating dependency and fuelling demand, as in the private …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £184 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£50 / $60/ €56 (excludes VAT)
You can download a PDF version for your personal record.